Pruritus in atopic dermatitis: a cross-sectional study of adult patients from a tertiary university hospital in São Paulo, Brazil.

An Bras Dermatol

Department of Dermatology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil. Electronic address:

Published: March 2025

Background: Chronic pruritus is the defining symptom of atopic dermatitis (AD). Although AD is common in Latin America, there is little data regarding pruritus intensity, characteristics, and effects on quality of life in this population.

Objective: This cross-sectional study aimed to evaluate pruritus in 91 patients with AD at a tertiary university hospital in São Paulo, Brazil. Patients aged 14‒65-years old were included in this study.

Methods: Patients completed the Itch Questionnaire, the ItchyQoL, and the POEM questionnaires and were asked to rate their itch severity using a 10-point peak pruritus Numerical Rating Scale (NRS). AD severity was assessed via the EASI and the vIGA-AD.

Results: The mean age was 29.68 ± 12.87years, and 56.0% of patients were White. 97.8% of patients were currently experiencing pruritus with an average NRS of 7.32 ± 2.22. Patients had associated bleeding (71.4%), heat sensation (63.7%), and pain (54.9%). Worsening factors included stress (93.4%), dry skin (91.2%), and sweat (75.8%). The mean total ItchyQoL score was 78.93 ± 17.20. Female gender was significantly associated with a higher total ItchyQoL score (p = 0.009). Pruritus on the neck, foot, and whole body was associated with higher total ItchyQoL scores in adjusted models (p < 0.05). The EASI, vIGA-AD, and POEM were moderately correlated with itch intensity (r = 0.434, 0.406, and 0.610) and total ItchyQoL score (r = 0.425, 0.436, and 0.631).

Study Limitations: The predominantly White population cohort may not be representative of the diverse AD phenotypes in the Brazilian patient population. Children under the age of 14 and adults over the age of 65 were excluded from the population cohort. Furthermore, patients included in the study may suffer from other non-dermatological diseases that cause itch, which may influence the outcomes oberserved.

Conclusions: Patients with AD in Brazil experience significant pruritus that impacts their quality of life. Gender, body location of itch, associated pain, and stress should all be taken into consideration when evaluating AD patients with pruritus.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.abd.2024.09.006DOI Listing

Publication Analysis

Top Keywords

total itchyqol
12
atopic dermatitis
8
cross-sectional study
8
patients tertiary
8
tertiary university
8
university hospital
8
hospital são
8
são paulo
8
paulo brazil
8
itchyqol score
8

Similar Publications

Pruritus in atopic dermatitis: a cross-sectional study of adult patients from a tertiary university hospital in São Paulo, Brazil.

An Bras Dermatol

March 2025

Department of Dermatology, Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil. Electronic address:

Background: Chronic pruritus is the defining symptom of atopic dermatitis (AD). Although AD is common in Latin America, there is little data regarding pruritus intensity, characteristics, and effects on quality of life in this population.

Objective: This cross-sectional study aimed to evaluate pruritus in 91 patients with AD at a tertiary university hospital in São Paulo, Brazil.

View Article and Find Full Text PDF

Bullous pemphigoid is a devastating autoimmune blistering disease with need for improved therapeutics. Limited data are available on the overall burden of pruritus and alterations over time; however, treatment of itch-specific pathways may provide novel therapeutics. In this paper, we analyzed the QOL impact particularly related to itch and determined corresponding changes in intraepidermal nerve fiber density and gene expression.

View Article and Find Full Text PDF
Article Synopsis
  • - Mycosis fungoides (MF) and Sézary syndrome (SS) are skin-related lymphomas that can significantly affect quality of life (HRQL), and a study found that patients treated with mogamulizumab reported better HRQL compared to those on vorinostat.
  • - A study involving 372 adults with relapsed MF or SS revealed that their HRQL was notably lower than normal averages, particularly affecting their emotional state and functioning due to factors like itchiness and overall health.
  • - Key demographic factors such as being female, younger, and having specific health conditions were linked to worse HRQL across different assessments, emphasizing the need to address these issues in patient care.
View Article and Find Full Text PDF
Article Synopsis
  • Anhedonia, the reduced ability to feel pleasure, is commonly seen in psychiatric disorders but hasn't been studied much in dermatological conditions like chronic itch, which is the focus of this study.
  • The researchers examined 137 patients and found that about 13.1% showed signs of anhedonia, particularly those suffering from severe itch, and discovered that anhedonia was significantly linked to higher itch severity, anxiety, depression, and decreased quality of life.
  • The findings suggest that addressing anhedonia could improve both mental health and treatment effectiveness for chronic itch, highlighting the need for future research to understand the connections further and create targeted interventions.
View Article and Find Full Text PDF
Article Synopsis
  • Studies showed that taking bleach baths helps improve symptoms of atopic dermatitis (AD), which is a skin condition that causes itchiness and rashes.
  • In a trial, 15 adults with AD took bleach baths twice a week for 12 weeks and many reported less itching and better sleep.
  • Results showed that their skin barrier improved, but bleach baths didn’t change the amount or presence of a certain bacteria called S. aureus on their skin.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!